4DMedical and Mayo Clinic announce the clinical deployment of CT VQ, an AI-driven respiratory imaging technology. Explore the future of lung health.
What the CT VQ Deployment Signals
4DMedical and Mayo Clinic have moved CT VQ from research into clinical deployment, which is the point at which an imaging technique stops being a proof of concept and starts informing decisions about real patients. The name itself describes the goal: pairing computed tomography (CT) with ventilation and perfusion (V/Q) assessment, the two halves of how a lung actually works. Ventilation is air moving in and out; perfusion is blood flowing through to pick up oxygen. A region of lung can look structurally intact on a standard scan and still be doing very little useful work if either side of that exchange is impaired.
The involvement of a large clinical institution matters more than any single feature. Deployment inside a working radiology practice means the output has to survive contact with clinicians who compare it against what they already see, order alongside existing tests, and reconcile with a patient's symptoms. That is a higher bar than a published result.
Function, Not Just Structure
Traditional lung imaging is very good at showing anatomy: where tissue is dense, where a nodule sits, where scarring has formed. What it shows less directly is function — how well air and blood are actually reaching each part of the lung. AI-driven analysis of CT data aims to close that gap by inferring regional function from the imaging already being captured, rather than requiring a separate, more involved procedure.
The practical appeal is that functional detail can appear before structure visibly changes, and it can be uneven across the lung in ways a single global measurement hides. A regional map of where breathing is working and where it is not gives a clinician something to localize and track over time.
Where This Could Help in Practice
Respiratory conditions are hard to manage partly because a patient's overall breathing tests average out local problems. A technique that resolves function region by region opens up several everyday uses:
- Spotting impaired areas earlier, when intervention has more room to work.
- Watching whether a treatment is improving function in the affected region, not just leaving the anatomy unchanged.
- Planning procedures around which parts of the lung are still contributing.
- Following chronic or post-illness lung damage over repeat visits with a consistent measure.
Because CT VQ works from CT imaging, it can potentially fit into workflows clinicians already run, rather than adding an entirely new appointment. That lowers the friction of adopting it and makes repeated measurement over time more realistic.
Reading the News With Appropriate Caution
A clinical deployment is a meaningful step, but it is a beginning rather than a verdict. The questions worth watching are the ordinary ones that decide whether any imaging tool earns lasting use: does it change what clinicians decide, does it hold up across different patients and scanners, and does it fit into a busy department without slowing care down. Those answers accumulate over time as more clinicians use it on more cases.
For anyone following lung health, the useful takeaway is directional. The trend is toward extracting functional, region-specific insight from imaging that is already routine, and toward AI that adds interpretation on top of existing scans instead of demanding new hardware. CT VQ at Mayo Clinic is one concrete instance of that direction reaching actual patients.